Search results
Results from the WOW.Com Content Network
Endocytosis is triggered when a specific receptor is activated in receptor-mediated endocytosis. The function of receptor-mediated endocytosis is diverse. It is widely used for the specific uptake of certain substances required by the cell (examples include LDL via the LDL receptor or iron via transferrin ).
Endocytosis is a cellular process in which substances are brought into the cell. The material to be internalized is surrounded by an area of cell membrane , which then buds off inside the cell to form a vesicle containing the ingested materials.
Low density lipoprotein receptor-related protein 1 (LRP1), also known as alpha-2-macroglobulin receptor (A2MR), apolipoprotein E receptor (APOER) or cluster of differentiation 91 (CD91), is a protein forming a receptor found in the plasma membrane of cells involved in receptor-mediated endocytosis. In humans, the LRP1 protein is encoded by the ...
Receptor mediated endocytosis is common way of turning receptors "off". Endocytic down regulation is regarded as a means for reducing receptor signaling. [40] The process involves the binding of a ligand to the receptor, which then triggers the formation of coated pits, the coated pits transform to coated vesicles and are transported to the ...
Receptor-mediated endocytosis Receptor-mediated endocytosis is a mode of pinocytosis. Proteins in the clathrin coat on the plasma membrane have propensity to bind and trap macromolecules or ligands. However, it is not the receptors in the pit that caused the pinocytosis. The vesicles would have formed regardless of whether or not the receptors ...
Molecules that follow these pathways include the receptors for LDL, epidermal growth factor (EGF), and the iron transport protein transferrin. Internalization of these receptors from the plasma membrane occurs by receptor-mediated endocytosis. LDL is released in endosomes because of the lower pH, and the receptor is recycled to the cell surface.
Immunoglobulin A from plasma cells in the mucosa are absorbed through receptor-mediated endocytosis on the basolateral surface and released as a receptor-IgA complex into the intestinal lumen. The receptor component confers additional stability to the molecule.
This process is illustrated by the insulin receptor sites on target cells, e.g. liver cells, in a person with type 2 diabetes. [6] Due to the elevated levels of blood glucose in an individual, the β-cells ( islets of Langerhans ) in the pancreas must release more insulin than normal to meet the demand and return the blood to homeostatic levels ...